Browsing by Yonsei Author : Cheon, Jae Hee

eperson profile image
Name:
Cheon, Jae Hee [천재희]
orcid http://orcid.org/0000-0002-2282-8904
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
Scopus (35200350500)

Keyword Cloud

Researcher Network

Showing results 1 to 50 of 389

This table browses all dspace content
Issue DateTitleJournal Title
2023Validation of the simplified magnetic resonance index of activity by using DWI without gadolinium enhancement to evaluate bowel inflammation in Crohn's diseaseEUROPEAN RADIOLOGY
2023Olfactomedin 4 produces dysplasia but suppresses metastasis of colon cancerCANCER GENE THERAPY
2023Interplay between chronic inflammation and clonal haematopoiesis of indeterminate potential in Behçet's disease ARTHRITIS RESEARCH & THERAPY
2023Long-term clinical outcomes of intestinal Behçet's disease: A 30-year cohort study at a tertiary hospital in South KoreaJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2023TRIM40 is a pathogenic driver of inflammatory bowel disease subverting intestinal barrier integrity NATURE COMMUNICATIONS
2023Risk Factors for Surgery in Patients with Intestinal Behçet's Disease During Anti-Tumor Necrosis Factor-Alpha Therapy YONSEI MEDICAL JOURNAL
2023Past, present, and future of Intestinal Research INTESTINAL RESEARCH
2023Factors associated with the prescription of probiotics in patients with inflammatory bowel disease: a cross-sectional study Journal of Yeungnam Medical Science
2023Comparing the efficacy of different methods of faecal microbiota transplantation via oral capsule, oesophagogastroduodenoscopy, colonoscopy, or gastric tubeJOURNAL OF HOSPITAL INFECTION
2023The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis INTESTINAL RESEARCH
2022Corticosteroids and Mesalamine Versus Corticosteroids for Acute Severe Ulcerative Colitis: A Randomized Controlled TrialCLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2022Aminoclay Nanoparticles Induce Anti-Inflammatory Dendritic Cells to Attenuate LPS-Elicited Pro-Inflammatory Immune Responses MOLECULES
2022Clinical Characteristics of Korean Patients with Elderly-Onset Crohn's Disease: Results from the Prospective CONNECT Study GUT AND LIVER
2022Microbial Modulation in Inflammatory Bowel Diseases IMMUNE NETWORK
2022Clinical Features and Long-term Prognosis of Crohn's Disease in Korea: Results from the Prospective CONNECT Study GUT AND LIVER
2022Improvement in Medication Adherence after Pharmacist Intervention Is Associated with Favorable Clinical Outcomes in Patients with Ulcerative Colitis GUT AND LIVER
2022Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α KOREAN JOURNAL OF INTERNAL MEDICINE
2022Early Infliximab Trough Levels Predict the Long-term Efficacy of Infliximab in a Randomized Controlled Trial in Patients with Active Crohn's Disease Comparing, between CT-P13 and Originator Infliximab GUT AND LIVER
2022Antiviral Prophylaxis Against Hepatitis B Virus in Patients Treated with Anti-Tumor Necrosis Factor α Agents for Inflammatory Bowel Disease GUT AND LIVER
2022Application of Multigene Panel Testing in Patients With High Risk for Hereditary Colorectal Cancer: A Descriptive Report Focused on Genotype-Phenotype CorrelationDISEASES OF THE COLON & RECTUM
2022Tumor-Suppressive Effect of Metformin via the Regulation of M2 Macrophages and Myeloid-Derived Suppressor Cells in the Tumor Microenvironment of Colorectal Cancer CANCERS
2022A GLP-1/GLP-2 receptor dual agonist to treat NASH: Targeting the gut-liver axis and microbiomeHEPATOLOGY
2022Smad4 and p53 synergize in suppressing autochthonous intestinal cancer CANCER MEDICINE
2022Efficient gene transfection to lung cancer cells via Folate-PEI-Sorbitol gene transporter PLOS ONE
2022Radiology plus ileocolonoscopy versus radiology alone in Crohn’s disease: prognosis prediction and mutual agreement KOREAN JOURNAL OF INTERNAL MEDICINE
2022Continued Postoperative Use of Tumor Necrosis Factor-α Inhibitors for the Prevention of Crohn's Disease Recurrence GUT AND LIVER
2022Novel Potassium-Competitive Acid Blocker, Tegoprazan, Protects Against Colitis by Improving Gut Barrier Function FRONTIERS IN IMMUNOLOGY
2022Rebleeding Rate and Risk Factors for Rebleeding after Device-Assisted Enteroscopy in Patients with Obscure Gastrointestinal Bleeding: A KASID Multicenter Study DIAGNOSTICS
2022Microbial changes in stool, saliva, serum, and urine before and after anti-TNF-α therapy in patients with inflammatory bowel diseases SCIENTIFIC REPORTS
2022Comparative effectiveness of second-line biological therapies for ulcerative colitis and Crohn's disease in patients with prior failure of anti-tumour necrosis factor treatment BMC GASTROENTEROLOGY
2022Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis BMJ OPEN GASTROENTEROLOGY
2022Impact of Visceral Fat on Survival and Metastasis of Stage III Colorectal Cancer GUT AND LIVER
2022Faecal microbiota transplantation reduces amounts of antibiotic resistance genes in patients with multidrug-resistant organisms ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL
2021Prognostic Value of Terminal Ileal Inflammation in Patients with Ulcerative Colitis GUT AND LIVER
2021Anti-inflammatory properties of Escherichia coli Nissle 1917 in a murine colitis modelINTESTINAL RESEARCH
2021C-reactive protein is associated with postoperative outcomes in patients with intestinal Behçet's disease BMC GASTROENTEROLOGY
2021An Escherichia coli strain with extra catalase activity protects against murine colitis by scavenging hydrogen peroxide and regulating regulatory t cell/interleukin-17 pathwaysFREE RADICAL BIOLOGY AND MEDICINE
2021Behçet syndromeNATURE REVIEWS DISEASE PRIMERS
2021Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management KOREAN JOURNAL OF INTERNAL MEDICINE
2021Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease? GUT AND LIVER
2021Efficacy and tolerability of infliximab retreatment in patients with inflammatory bowel disease: a systematic review and meta-analysis THERAPEUTIC ADVANCES IN CHRONIC DISEASE
2021Early course of newly diagnosed moderate-to-severe ulcerative colitis in Korea: Results from a hospital-based inception cohort study (MOSAIK)JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2021Infliximab Biosimilar CT-P13 Observational Studies for Rheumatoid Arthritis, Inflammatory Bowel Diseases, and Ankylosing Spondylitis: Pooled Analysis of Long-Term Safety and EffectivenessADVANCES IN THERAPY
2021A transepithelial pathway delivers succinate to macrophages, thus perpetuating their pro-inflammatory metabolic state CELL REPORTS
2021Deep-learning system for real-time differentiation between Crohn's disease, intestinal Behçet's disease, and intestinal tuberculosisJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2021The real-world outcomes of vedolizumab in patients with ulcerative colitis in Korea: a multicenter retrospective study THERAPEUTIC ADVANCES IN GASTROENTEROLOGY
2021Succinate-treated macrophages attenuate dextran sodium sulfate colitis in mice INTESTINAL RESEARCH
2021Patterns of Locoregional Recurrence after Radical Cystectomy for Stage T3-4 Bladder Cancer: A Radiation Oncologist's Point of View YONSEI MEDICAL JOURNAL
2021Physical activity and quality of life of patients with inflammatory bowel disease MEDICINE
2021Proteomic analysis-based discovery of a novel biomarker that differentiates intestinal Behçet's disease from Crohn's disease SCIENTIFIC REPORTS

Browse

Links